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Chapter I
Introduction
I. Introduction
Accurate protein biosynthesis is a vital process to all cellular life. Aminoacyl-tRNAs
are at the heart of this process. A correctly aminoacylated tRNA fulfills two important
roles in protein synthesis – First, it establishes a connection between information in the
genetic code and its accurate representation as amino acids in proteins. Second, as a
chemical entity, it serves as an activated monomer to facilitate peptide bond formation
in the ribosome with ease.
The correct synthesis of aminoacyl-tRNAs requires matching of the cognate tRNA to
the cognate amino acid. There are two challenges for such a task. Organisms can have
tRNA encoding genes ranging from 15(ref) to as high as 620(ref). Aminoacylation thus
requires selecting the correct tRNA from a large number of tRNAs. Similarly, the
cognate amino acid has to be selected from a cellular pool of 20 amino acids and many
structurally similar secondary metabolites. This complex task is carried out by a family
of enzymes called the aminoacyl-tRNA synthetases (aaRSs). Once correctly formed,
the aminoacyl-tRNA pair is shuttled to the ribosome by EF-Tu. Mechanisms to maintain
the fidelity of these processes are essential for the integrity of the genetic code. An
understanding of the above machinery is thus important for understanding the protein
biosynthesis pathway of organisms.
This chapter will provide a background on the agents involved in aminoacyl-tRNA
synthesis and consumption. In particular, how Helicobacter pylori, a human pathogen,
synthesizes its aminoacyl-tRNAs will be discussed. In conclusion, the chapter will
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outline the dissertation research carried out on the indirect aminoacylation synthesis of
Gln-tRNAGln in H. pylori using phylogenetic analyses and enzymatic assays.
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II. Transfer RNAs
tRNAs have
ave a distinctive secondary structure – the cloverleaf shown in Figure 1.1a,
that consists of four regions. They are described below.

Gln

Figure 1.1 The secondary (a) and tertiary (b) structure of E. coli tRNA

. The acceptor
a
stem is

shown in red; the D-stem/loop is in blue; the anticodon stem/loop is in green with the anticodon in
black; the variable loop is in gray;; and the TΨC stem/loop is in light blue. PDB ID: 1GTS (Courtesy: Dr.
Keng-Ming Chang)

The acceptor stem – This region contains both the 5’ and 3’ ends of the tRNA and is
usually 7 bp long with four extra ribonucleotides on the 3’
3’-end.
end. The trinucleotides CCA
are the last three for any tRNA molecule. They can be added post
post-transcriptionally
transcriptionally or
o be
a part of the encoded tRNA sequence. The identity of the fourth unpaired nucleotide
varies for different tRNA molecules. This position is called the discriminator base and is
important for substrate recognition by some aaRSs.18, 19
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The D stem/loop – This region consists of 3-4 base pairs in the stem and about 8
unpaired ribonucleotides in the loop. Most uridine bases in the loop are posttranscriptionally reduced to dihydrouridine, abbreviated D. This region can also play a
role in aaRS recognition depending on the length of the D stem.14, 16 The D loop makes
several contacts with the variable loop to form the stable tertiary structure of tRNA (see
below).
The anticodon stem/loop – This region carries about 5 base pairs in its stem and a
triplet of ribonucleotides (anticodon) in the loop that serves to decode the information in
mRNA by Watson-Crick pairing with the corresponding codons. The anticodon loop is
heavily modified post-transcriptionally and the nucleotides adjacent to the anticodon as
well as the anticodon itself are often important identity elements for aaRSs.

6,9,18

The

nucleotides in the anticodons can also be post-transcriptionally modified. For example,
U34 in tRNAGln is thiolated and this modification is critical for tRNA aminoacylation and
specificity.21
The TψC stem/loop – This region has the conserved triplet UUC in its loop. Posttranscriptional modifications convert the first uridine to thymidine (T) by methylation
while the second uridine is converted to psuedouridine (Ψ). Hence, this region is called
the TψC region. Three base pairs in the stem are important for recognition by EF-Tu
(see section 1.7 below).
Nearly all tRNAs fold into a characteristic L-shaped tertiary structure (Figure 1.1b).
The anticodon is at one end in this structure while the free 3’ – hydroxyl of the terminal
ribose in the acceptor stem is on the other end. The two ends are separated by a
distance of approximately 70 Å. The tRNA variable loop, which can have 4-20
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nucleotides, forms tertiary contacts with positions in the D stem and D loop to form the
hinge (or elbow region) of the tRNA. This structure leaves the anticodon triplet unpaired
and available for Watson-Crick base pair formation with codons in mRNA.
A tRNA molecule typically encounters an average of 30 different enzymes after its
transcription till its consumption. The selective recognition of a particular tRNA over
others depends on the presence or absence of certain nucleotides in its primary
sequence. The nucleotides that aid recognition are termed “determinants,” while the
ones that disfavor it are called “antideterminants”. As noted above, the determinants
and antideterminants for various enzymes (including aaRSs) are scattered throughout
the body of tRNA. The presence of such an identity set for each protein that interacts
with a particular tRNA thus constrains the primary sequence and the number of possible
isoacceptors of tRNA for a particular anticodon.18
Considerations about identity sets for various tRNA interacting proteins play an
important role in the goal of engineering microbes with desired properties. For example,
constraints on the primary tRNA sequence were exploited in designing a tRNA molecule
capable of introducing phosphoserine into the genetic code of E Coli.22 With the
accelerated pace of synthetic biology, such expanded genetic codes and their host
microbes are expected to play a key role in uncovering and generating desired
properties of living systems.27

III. Aminoacyl-tRNA synthetases (aaRSs)
Aminoacyl-tRNA synthetases synthesize aminoacyl-tRNAs by catalyzing two
reactions. In the first reaction, the amino acid is activated by by ATP to form aminoacyl-
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adenylate (aa-AMP, Figure 1.2). For certain aaRSs like LysRS I, GluRS, GlnRS, and
ArgRS this step requires the presence of the corresponding tRNA.1,

4

In the second

step, the activated aa-AMP reacts with the 2’ or 3’ hydroxyl of the terminal ribose in the
cognate tRNA to form the aminoacyl-tRNA (aa-tRNA).

Figure 1.2 Aminoacyl-tRNA synthesis by the aaRSs. (a) The aaRS activates its cognate amino acid
using ATP to form aa-AMP. (b) This aa-AMP is then reacted with the cognate tRNA to form the aa-tRNA.

Since all aaRSs catalyze the same two reactions, the sequence-structure-function
dogma11 leads to the expectation that these enzymes should share conserved features
in their primary sequences, their overall structure, as well as their biochemical mode of
catalysis. As will be discussed below, this is not the case. As a family of enzymes,
aaRSs can thus be viewed as one of the counter-examples to the sequence-structurefunction dogma, among many others.12
The family of aaRSs has been classified into two classes – Class I and Class II.
Members of each class share sequence, structure, and mechanistic features. Subtle
differences lead to a sub-division of classes; these will however not be discussed here.
Class I synthetases have conserved HIGH and KMSKS signature sequences.1
These sequences are a part of the nucleotide-binding domain – the Rossmann fold2 –
that is part of the active site of these enzymes. The Rossman fold binds ATP in an
extended form, while the HIGH and KMSKS motifs stabilize the transition state of the
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first reaction – aa-AMP formation1. The binding of Class I aaRSs to the minor groove of
the acceptor stem of the tRNA is followed by nucleophilic attack by the 2’ hydroxyl of the
3’ end of the tRNA towards the aa-AMP, generating the aa-tRNA2. The anticodonbinding domain of most Class I aaRSs is an alpha-helix bundle. The only known
exception is GlnRS, here the anticodon-binding domain is made of β-sheets. Four Class
I synthetases – GluRS, GlnRS, ArgRS and LysRS I – require cognate tRNA binding1
before aa-AMP formation.
Class II aaRSs differ from their Class I counterparts on several counts. They have
three conserved domains – domains I, II and III2. Domains II and III form the active site
with an antiparallel β−fold2. Most Class II aaRSs are dimeric or multimeric in contrast to
the monomeric Class I aaRSs. Domain I forms the dimer interface2. The rigid β-fold
leads to ATP binding in a bent form with positioning of the amino acid for nucleophilic
attack. The binding of Class II aaRSs to their cognate tRNAs is from the major groove
leading to conformational changes in the anticodon loop1. The aminoacylation takes
place on the 3’ hydroxyl of the 3’end of tRNA.
IV. Expectation of ubiquity – and the revelation.
Protein biosynthesis primarily relies on twenty encoded amino acids. Consequently,
it seems reasonable to expect that twenty aaRSs are required to generate the required
twenty aa-tRNA pairs for protein synthesis. Thus, all life would utilize twenty aaRSs in
their protein biosynthesis machinery. Contrary to this expectation, however, “many
organisms utilize a limited (<20) set of aaRSs or a non-standard set of aaRSs or tRNA
aminoacylation mechanisms”. 6
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It is no longer surprising that there are exceptions to the twenty aaRSs per organism
rule. Eukaryotes almost exclusively follow this rule. Many bacteria and almost all
archaea, however, do not have a complete set of aaRSs. Thus, most of the life that we
know does not obey this rule. The remainder of this chapter as well as the rest of this
thesis will discuss the possibilities raised by this revelation.
The most ubiquitous of the missing synthetases are glutaminyl-tRNA synthetase
(GlnRS) and asparaginyl-tRNA synthetase (AsnRS). These two aaRSs are missing in
Helicobacter pylori,7 an organism whose tRNA aminoacylation pathways are of interest
to our lab. The different route taken by H. pylori to the products of these enzymes are
discussed separately in the next section.
V. Gln-tRNAGln and Asn-tRNAAsn biosynthesis in H. pylori
The complete genome of the human pathogen Helicobacter pylori revealed that
genes encoding for both GlnRS and AsnRS are missing.7 Like many other organisms
that are missing these genes, H. pylori uses indirect pathways to synthesize AsntRNAAsn and Gln-tRNAGln.
For Asn-tRNAAsn production, a non-discriminating aspartyl-tRNA synthetase (NDAspRS) catalyzes the formation of both Asp-tRNAAsp and Asp-tRNAAsn (Figure 1.3). The
misacylated Asp-tRNAAsn is then converted to the cognate Asn-tRNAAsn by
transamidation (see section VI, below).
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Asp

Figure 1.3 Reactions catalyzed by ND-AspRS: Both tRNA
AspRS to give the cognate Asp-tRNA

Asp

Asn

and tRNA

Asn

and the non-cognate Asp-tRNA

are aspartylated by ND-

(colored in red).

Similar to ND-AspRS, organisms missing GlnRS usually utilize an analogous NDGluRS for synthesis of Glu-tRNAGlu and Glu-tRNAGln (Figure 1.4). Just like above, the
misacylated Glu-tRNAGln is converted to Gln-tRNAGln by transamidation (see section VI)

Glu

Figure 1.4 Reactions catalyzed by ND-GluRS: Both tRNA
Glu

GluRS to give the cognate Glu-tRNA

Gln

and tRNA
Gln

and the non-cognate Glu-tRNA

are glutamylated by ND-

(colored in red).

However, H. pylori, a representative of the ε-proteobacteria, takes a slightly different
path to produce Gln-tRNAGln. H. pylori has two copies of the gltX gene, apparently
generated by a gene duplication event.9 GluRS1 catalyzes the direct aminoacylation of
Glu-tRNAGlu and thus acts as a D-GluRS (Figure 1.5). GluRS2 (in contrast to ND-

10
GluRS) selectively aminoacylates tRNAGln to form Glu-tRNAGln.9 (Figure 1.5) The
misacylated Glu-tRNAGln is repaired by transamidation.

Gln

Figure 1.5 Aminoacylation of tRNA

Glu

and tRNA

in H. pylori: The two tRNA
Glu

glutamylated by GluRS1 (blue) to form cognate Glu-tRNA

glutamylated by GluRS2 to form the non-cognate Glu-tRNA

Glu

isoacceptors are

Gln

. Transfer RNA

is selectively

Gln

. Protein structures are Rosetta

28

models.

As discussed above, synthetases with relaxed or non-cognate specificities generate
misacylated tRNAs, like Asp-tRNAAsn and Glu-tRNAGln. In organisms like H. pylori, they
are converted to the cognate Asn-tRNAAsn and Gln-tRNAGln by transamidation. This
reaction catalyzed by an amidotransferase is discussed below. For simplicity, only GlntRNAGln synthesis is discussed. Similar discussion applies to Asn-tRNAAsn synthesis.
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VI. The amidotransferase GatCAB in H. pylori
As discussed above, the misincorporation of Glu-tRNAGln is prevented by its
conversion into Gln-tRNAGln by a heterotrimeric protein complex called GatCAB (Figure
1.6B).8

Gln

Figure 1.6: Indirect aminoacylation pathway for H. pylori Gln-tRNA
Gln

tRNA

. A: Hp GluRS2 glutamylates

Gln

to generate Glu-tRNA

. B. H. pylori GatCAB rescues this misacylation by a transamidation
Gln

reaction, using glutamine as the ammonia donor, to convert Glu-tRNA

Gln

into Gln-tRNA

.

GatCAB is a heterotrimeric amidotransferase consisting of 3 subunits – GatC,
GatA, and GatB.10 GatCAB catalyzes three reactions: Glutaminase (glutamine
hydrolysis, catalyzed by GatA); Phosphorylation of Glu-tRNAGln (catalyzed by GatB),
and transamidation (transport of ammonia from GatA to GatB and its reaction with the
phosphorylated intermediate to generate Gln-tRNAGln, catalyzed by GatB). The role of
GatC is not known. The ammonia generated by glutamine hydrolysis in GatA remains
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associated with the enzyme and is delivered through a tunnel to the active site of GatB.
There, the ammonia nucleophilically attacks the phosphorylated amino acid to generate
Gln-tRNAGln (Summarized in Figure 1.7).6

Figure 1.7: Reactions catalyzed by GatCAB:

6

Rxn 1: GatA catalyzes the hydrolysis of glutamine to
Gln

generate ammonia. Rxn 2: GatB catalyzes the phosphorylation of Glu-tRNA

to form a mixed anhydride.

Rxn 3: The ammonia from GatA is transported to the active site of GatB where it acts as a nucleophile to
Gln

generate Gln-tRNA

. Figure from reference 6.

Such a rescue of misacylation is not unique to bacteria. In archaea, transamidation
is performed by GatDE23 while in organellar systems like mitochondria, etc (which are
thought to be

bacterial in

origin) the heterotrimeric

GatFAB

performs

the

transamidation24.
VII. Elongation factor (EF-Tu)
Generation of a correctly aminoacylated tRNA is closely followed by its consumption
in the ribosome for protein synthesis. These two processes are bridged by elongation

13
factor Tu (EF-Tu). EF-Tu, in its GTP bound form, shuttles the correctly formed aa-tRNA
to the ribosome. Here, hydrolysis of the bound GTP by EF-Tu releases the aa-tRNA for
protein biosynthesis. 25
Elegant studies have shown that EF-Tu recognizes the correct pair by
“thermodynamic compensation.”26 Briefly, the binding affinity of a given aa-tRNAaa to
EF-Tu consists of the combined contributions of the amino acid and the first three base
pairs in the TΨC stem of the tRNA. These contributions follow a bell-shaped distribution.
An amino acid with a higher affinity for EF-Tu is matched with a tRNA with a lower
affinity and vice-versa. The net effect is the uniform binding affinity of Ef-Tu to aatRNAs.
The Uhlenbeck model is thus another checkpoint in accurate protein biosynthesis.
The power of such a model is that it allows engineering the three triplets so as to
influence the binding of EF-Tu to a (cognate or non-cognate) tRNA pair.22

VIII. Dissertation research
This dissertation focuses on indirect aminoacylation and transamidation to produce
Gln-tRNAGln in H. pylori. A combination of phylogenetic analyses and enzymatic assays
were used that contribute to a picture of this process.
Chapter 2 discusses our examination of sequence conservation of gltX2 (the gene
that encodes GluRS2) across different H. pylori strains. The conclusions of this
sequencing effort are compared with trends in sequences of genes important in the
aminoacylation step of protein synthesis.
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Chapter 3 discusses one aspect of Gln-tRNAGln production – the mechanism of
transport of ammonia from the active site of one subunit (GatA) to the active site of
another (GatB) through an intramolecular hydrophilic tunnel. Site-directed mutagenesis
of key residues lining this tunnel and their transamidation assays were performed. With
these studies, a preliminary picture of ammonia transport through the tunnel can be
constructed.
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Chapter II
Sequencing gltX2 genes in Hp strains
I. Introduction
It is evident from genomic analyses that known glutaminyl-tRNA synthetases
(GlnRS) originated in eukarya. Some bacteria do possess a GlnRS (e.g.E.coli), however
these enzymes are products of horizontal gene transfer from eukarya.1To date, no
GlnRS has been found that originated in archaea or in most bacteria.
The hypothesis, therefore, for the evolution of GlnRS is as follows: An ancient nondiscriminating glutamyl-tRNA synthetase (ND-GluRS) gene underwent a gene
duplication event to give two ND-GluRSs. After branching from archaea, the eukarya
were able to evolve these into a D-GluRS and D-GlnRS. A few bacteria acquired this
D-GlnRS through horizontal gene transfer, as mentioned above. Many archaea and
bacteria continue to utilize a ND-GluRS for production of Glu-tRNAGlu and Gln-tRNAGln
by direct and indirect aminoacylation pathways, respectively.2
A few bacteria, including Helicobacter pylori (Hp), have retained duplicate copies of
the gltX gene. In H. pylori, GluRS1 is a discriminating GluRS, while GluRS2 has been
proposed to be a missing evolutionary link between an ND-GluRS and a forthcoming DGlnRS of bacterial origin.3
Because Hp is a highly adaptive organism, it has a high rate of evolutionary
variation between strains. In fact, strains of H. pylori that have been isolated from
different regions of the world differ substantially in infectivity and are genomically
varied.4 This fact provides us with a unique opportunity to study the possible evolution
of GluRS2 into a bacterial GlnRS.
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Previously, Dr. Terry Cathopoulis had cloned (into the TOPO pCR2.1 vector,
Invitrogen) and sequenced 16 GluRS2 genes from genomic DNA of different Hp strains
(These strains were chosen because they are representative of the geographic
distribution of Hp).5 Not surprisingly, most of these genes were highly homologous to
the gltX2 gene from Hp26695, the strain used for our original characterization of
GluRS1 and GluRS2.3 However, two sequences were potentially interesting. The first of
these is called as the Cheetah strain, a strain of Hp that infects cheetahs. The Cheetah
gltX2 gene contained a premature stop codon leading to a predicted open reading
frame thatencoded a truncated copy of GluRS2 (only the first 150 of GluRS2’s 450
amino acids were encoded). The same gene in another Hp strain called R7 also
contained a premature stop codon and was predicted to encode protein 394 amino
acids in length. Finally, adequate sequencing data for thegltX2 gene from the B3 strain
was not obtained. Because these results were intriguing and were the result of only one
evaluation, the goal of this aim was to revisit and hopefully confirm the Cheetah and R7
truncations and to complete the evaluation of the gltX2 gene from strain B3.
II. Results and Discussion
The gltX2 gene was amplified from the B3 Hp strain using primers NJ201 and
NJ202 and the polymerase chain reaction (PCR). The products were cloned into the
TOPO pCR2.1 vector and sequenced. The alignment of B3 with Hp 26695 is shown in
Figure 1A. The two genes were highly homologous and so further evaluations of B3
were deemed unnecessary.
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Figure 2.1: Alignment of DNA sequences for the gltX genes from Hp strain 26695
versus B3.
26695
B3

ATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCACATAGGGAATTTAAGGGCAGCC 60
ATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCACATAGGGAATTTAAGGGCAGCC 60
************************************************************

26695
B3

ATTTTCAACTACATTGTGGCTAAACAGCAATATAAACCCTTTCTCATTCGCATTGAAGAC 120
ATTTTCAATTACATTGTGGCCAAACAGCAACACAAACCCTTTCTCATTCGCATTGAAGAC 120
******** *********** ********* * ***************************

26695
B3

ACAGACAAAGAGCGCAACATTGAAGGCAAAGACCAAGAGATTTTAGAAATTTTAAAGCTT 180
ACGGACAAAGAGCGCAACGTTGAAGGCAAAGACCAAGAGATTTTAGAAATTTTAAAGCTT 180
** *************** *****************************************

26695
B3

ATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCATAATATAGATTACCACAGAGAA 240
ATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCATAACATAGATTATCACAGAGAA 240
***************************************** ******** *********

26695
B3

ATGGCAGAAAAATTACTGAAAGAAAATAAAGCGTTTTATTGTTATGCGAGTGCGGAGTTT 300
ATGGCAGAAAAATTACTGAAAGAACATAAAGCGTTTTATTGTTATGCGAGCGCGGAGTTT 300
************************ ************************* *********

26695
B3

TTAGAAAGAGAAAAAGAAAAAGCCAAAAATGAAAAACGCCCTTTCAGGTATTCAGACGAG 360
TTAGAAAGAGAAAAAGAAAAAGCCAAAAACGAGAAACGCCCTTTCAGGTATTTAGACGAG 360
***************************** ** ******************* *******

26695
B3

TGGGCCACTTTAGAAAAAGACAAGCACCATGCCCCTGTGGTGCGTTTAAAAGCCCCAAAT 420
TGGGCCACTTTAGAAAAAGACAAGCATCATGCCCCTGTGGTGCGTTTAAAAGCCCCAAAT 420
************************** *********************************

26695
B3

CATGCGGTGTCTTTCAACGATGCGATTAAAAAAGAAGTGAAATTTGAACCTGATGAATTG 480
CATGCGGTGTCTTTCAATGATGCGATTAAGAAAGAAGTGGAATTTGAGCCTGATGAATTG 480
***************** *********** ********* ******* ************

26695
B3

GATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACTTATAATTTCGCTTGCGCATGC 540
GATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACTTATAATTTCGCTTGCGCATGC 540
************************************************************

26695
B3

GATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGCGAAGATCATGTGAGTAACACC 600
GATGATTTGCTCTATGAAATCAGTCTGATTATTAGAGGCGAAGATCATGTGAGTAACACC 600
*********** *** ********************************************

26695
B3

CCCAAACAAATCTTAATCCAGCAAGCTTTAGGCTCCAATGATCCGATTGTTTATGCGCAT 660
CCTAAACAAATCTTAATCCAGCAAGCTTTAGGCTCAAACGATCCGATTGTTTATGCGCAT 660
** ******************************** ** *********************

26695
B3

TTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATGAGTAAAAGAGATGAAGCCTCC 720
TTACCCATTATTTTAGATGAAACAAGCGGTAAAAAAATGAGCAAAAGAGACGAAGCCTCC 720
** ****************** ************ ***** ******** *********

26695
B3

AGCGTGAAATGGCTTTTGAATCAAGGGTTTTTACCGGTTGCGATTGCGAATTACCTCATC 780
AGCGTGAAATGGCTTTTGAATCAAGGGTTTTTGCCGGTTGCGATTGCAAATTACCTCATC 780
******************************** ************** ************

26695
B3

ACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGATGAAGCGATAGAATGGTTT 840
ACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGATGAAGCGATAGAATGGTTT 840
************************************************************

26695
B3

AGTTTAGAAAATCTTTCCAGTTCTCCGGCTCATTTTAATTTAAAATATTTAAAACACTTA 900
AGTTTAGAAAATCTTTCCAGTTCCCCGGCTCATTTTAATTTAAAATATTTAAAACACTTA 900
*********************** ************************************

26695
B3

AACCACGAGCATTTAAAGCTTTTAGACGATGACAAGTTATTAGAACTCACTTCAATAAAA 960
AACCACGAGCATTTAAAGCTTTTAGACGATGAAAAGTTATTAGAACTCACTTCAATAAAA 960
******************************** ***************************

26695

GATAAAAACCTCTTAGGGCTTTTAAGATTGTTTATAGAAGAATGCGGCACGCTTTTAGAA 1020

20
B3

GATAAAAACCTCCTAGGGCTTTTAAGATTGTTTGTAGAAGAATGCGGTACGCTTTTAGAA 1020
************ ******************** ************* ************

26695
B3

TTGAGGGAAAAAATTTCGTTGTTTTTAGAGCCAAAGGATATTGTTAAAACTTATGAAAAT 1080
TTGAAAGAAAAAATTTCGTTGTTTTTAGAGCCAAAGGATATTGTTAAAACTTATGAGAAC 1080
**** ************************************************** **

26695
B3

GAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACGCTCTAACAAGCATGGATTTTCAA 1140
GAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACGCCCTAAAAGGCATGGATTTTCAA 1140
************************************** **** * **************

26695
B3

GCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGCGATTAAGCCAGCTTAAGGGT 1200
GCGTATAAGGATTTTGAAAGCTTTAAAAAAGAAGCCATGCGATTAAGTCAGCTTAAGGGT 1200
******************** ************************** ************

26695
B3

AAGGATTTTTTCAAACCTTTGCGCATCCTTTTAACCGGGAACTCGCATGGCGTTGAATTG 1260
AAGGATTTTTTCAAACCTTTGCGCATTCTTTTAACCGGGAACTCGCATGGCATTGAATTG 1260
************************** ************************ ********

26695
B3

CCTTTGATTTTCCCCTATATCCAAAGCCATCATCAAGAAGTTTTAAGGCTCAAAGCATGA 1320
CCTTTGATTTTCCCCTATATCCAAAGCCACTATCAAGAAGTTTTAAGGCTCAAAGCATGA 1320
***************************** *****************************

The gltX2 gene wasPCR amplified from the Cheetah Hp strain using primers NJ201
and NJ202. The products were cloned into the TOPO pCR2.1 vector and sequenced.
Surprisingly, the sequences showed a considerable number of mismatches compared
to the previous data reported by Dr. Cathopoulis. In order to get an unambiguous
sequence, we repeated the above experiment using primers S3 and S4 (the ones
originally used by Dr. Cathopoulis).
The sequences from the latter effort matched our own results and continued to
show mismatches with the preliminary data. With one exception (below), our data
aligned with very good agreement to the gltX2 gene fromHp 26695.These results are
shown in Figures 2.2 and 2.3. Based on a 3:1 occurrence, we have concluded that gltX2
gene from Cheetah is not truncated as originally suspected.
Figure 2: Alignment of sequencing data using forward primers for the strain
Cheetah gltx2. NJ; S3 and S4 – data from different sequencing trials. TC – Data from Dr.
Terry Cathopulis. 26695 – Data from H pylori genome.
NJ
S3 & S4
26695
TC

---NGNGANTGGGCCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGC
NNGGGCGANTGGGCCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGC
-----------------------------------------------------------------------------------------------------------------------
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NJ
S3 & S4
26695
TC

AGAATTCGCCCTTCGGGATCCATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCAC
AGAATTCGCCCTTCGGGATCCATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCAC
---------------------ATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCAC
---------------------ATGCTTCGTTTTGCGCCTTCGCCTACTGGGGATATGCAC
************************** ************

NJ
S3 & S4
26695
TC

ATAGGGAATTTAAGGGCAGCCATTTTCAACTACATTGTGGCTAAACAGCAATATAAACCC
ATAGGGAATTTAAGGGCAGCCATTTTCAACTACATTGTGGCTAAACAGCAATATAAACCC
ATAGGGAATTTAAGGGCAGCCATTTTCAACTACATTGTGGCTAAACAGCAATATAAACCC
ATAGGGAATTTAAGGGCAGCCATTTTTAACTATATTGTGGCTAAACAGCAACATAAACCC
************************** ***** ****************** ********

NJ
S3 & S4
26695
TC

TTTCTCATTCGCATTGAAGACACAGACAAAGAGCGCAACATTGAAGGCAAAGACCAAGAG
TTTCTCATTCGCATTGAAGACACAGACAAAGAGCGCAACATTGAAGGCAAAGACCAAGAG
TTTCTCATTCGCATTGAAGACACAGACAAAGAGCGCAACATTGAAGGCAAAGACCAAGAG
TTTCTCATTCGCATTGAAGACACAGATAAAGAGCGCAATATTGAAGGCAAAGATCAGGAG
************************** *********** ************** ** ***

NJ
S3 & S4
26695
TC

ATTTTAGAAATTTTAAAGCTTATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCAT
ATTTTAGAAATTTTAAAGCTTATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCAT
ATTTTAGAAATTTTAAAGCTTATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCAT
ATTTTAGAGATTCTAAAGCTCATGGGAATGAACTGGGATAAACTCGTGTATCAAAGCCAT
******** *** ******* ***** ** * ****** ** ******************

NJ
S3 & S4
26695
TC

AATATAGATTACCACAGAGAAATGGCAGAAAAATTACTGAAAGAAAATAAAGCGTTTTAT
AATATAGATTACCACAGAGAAATGGCAGAAAAATTACTGAAAGAAAATAAAGCGTTTTAT
AATATAGATTACCACAGAGAAATGGCAGAAAAATTACTGAAAGAAAATAAAGCGTTTTAT
AACATAGATTACCATAGGGAAATGGCAGAAAAATTGCTTAAAGAAAATAAGGCGTTTTAT
** *********** ** ***************** ** *********** *********

NJ
S3 & S4
26695
TC

TGTTATGCGAGTGCGGAGTTTTTAGAAAGAGAAAAAGAAAAAGCCAAAAATGAAAAACGC
TGTTATGCGAGTGCGGAGTTTTTAGAAAGAGAAAAAGAAAAAGCCAAAAATGAAAAACGC
TGTTATGCGAGTGCGGAGTTTTTAGAAAGAGAAAAAGAAAAAGCCAAAAATGAAAAACGC
TGTTATGCGAGTGTGGGATTTTTAGAACAAGAAAAAGAAAAAGCCAAAAACGAAAAACGC
************* ** ********* ********************* *********

NJ
S3 & S4
26695
TC

CCTTTCAGGTATTCAGACGAGTGGGCCACTTTAGAAAAAGACAAGCACCATGCCCCTGTG
CCTTTCAGGTATTCAGACGAGTGGGCCACTTTAGAAAAAGACAAGCACCATGCCCCTGTG
CCTTTCAGGTATTCAGACGAGTGGGCCACTTTAGAAAAAGACAAGCACCATGCCCCTGTG
CCTTTCAGGTATTTAGATGAATGGGCGGCTTTAGAGAAAAACCAGCACAATACCCCTGTG
************* *** ** ***** ******* *** ** ***** ** ********

NJ
S3 & S4
26695
TC

GTGCGTTTAAAAGCCCCAAATCATGCGGTGTCTTTCAACGATGCGATTAAAAAAGAAGTG
GTGCGTTTAAAAGCCCCAAATCATGCGGTGTCTTTCAACGATGCGATTAAAAAAGAAGTG
GTGCGTTTAAAAGCCCCAAATCATGCGGTGTCTTTCAACGATGCGATTAAAAAAGAAGTG
GTGCGTTTAAA-GCCCCAAATCATGCGGTGTCTTTTAACGATGCGATTAAAAAAGAAGTG
*********** *********************** ************************

NJ
S3 & S4
26695
TC

AAATTTGAACCTGATGAATTGGATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACT
AAATTTGAACCTGATGAATTGGATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACT
AAATTTGAACCTGATGAATTGGATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACT
AAATTTGAGCCTTATGAATTGGATTCTTTTGTGCTTTTAAGAAAGGATAAGAGCCCTACT
******** *** ************************* *** ******* *********

NJ
S3 & S4
26695
TC

TATAATTTCGCTTGCGCATGCGATGATTTGCTTTATAAAATCAGTCTGATTATTTGCGGC
TATAATTTCGCTTGCGCATGCGATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGC
TATAATTTCGCTTGCGCATGCGATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGC
TATAATTTCGCTTGTGCATGCGATGATTTGCTTTATGAAATCAGTCTTATTATTAGGGGC
************** ********************* ********** ****** * ***

NJ
S3 & S4
26695
TC

GAAGATCATGTGAGTAACACCCCCAAACAAATCTTAATCCAGCAAGCTTTAGGCTCCAAT
GAAGATCATGTGAGTAACACCCCCAAACAAATCTTAATCCAGCAAGCTTTAGGCTCCAAT
GAAGATCATGTGAGTAACACCCCCAAACAAATCTTAATCCAGCAAGCTTTAGGCTCCAAT
GAAGATCATGTGAGTAACACCCCTAAACAAATCTTAATCCAACAAGCTTTAGGCTCCAAC
*********************** ***************** *****************

NJ
GATCCGATTGTTTATGCGCATTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATG
S3 & S4 GATCCGATTGTTTATGCGCATTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATG
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26695
GATCCGATTGTTTATGCGCATTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATG
TC
AACCCTATTATTTATGCACATTTGCCCATTATCTTAGATGAAGCAAGCGGTAAAAAGATG
* ** *** ******* ************** ********** ****************
NJ
S3 & S4
26695
TC

AGTAAAAGAGATGAAGCCTCCAGCGTGAAATGGCTTTTGAATCNANGGGTTTTTACCGGT
ANTAAAAGAGATGAAGCCTCCAGCGTGAAATGGCTTTTGAATCNANGGGTTTTTACCGGT
AGTAAAAGAGATGAAGCCTCCAGCGTGAAATGGCTTTTGAATCAAGGG-TTTTTACCGGT
AGCAAAAGGGATGAAGCCTCTAGCGTGAAATGGCTTTTAAATCAAGGG-TTTTTGCCGGT
* ***** *********** ***************** **** * ** ***** *****

NJ
S3 & S4
26695
TC

TGCGATTGCGAATTACCTCATCACTATCGGTAATAAAGTGCCNNANGGAAGTTTTTAGCC
TGCGATTGCGAATTACCTCATCACTATCGGTAATAAAGTGCCTAANN-AAGTTTTTAGCC
TGCGATTGCGAATTACCTCATCACTATCGGTAATAAAGTGCCTAAGG-AAGTTTTTAGCC
TGCTATTGTGAATTACCTCATCACTATTGGTAATAAAGTGCCTAAAG-AAGTTTTTAGCC
*** **** ****************** ************** *
************

NJ
S3 & S4
26695
TC

TTGATGAN-CGATAGAATGGNTTANTTTAGAAAATCTTTNCAGNNN--CNGNNTCNTTTN
NTGATGAAGCGATAGAATGGTTTANTTTAGAAAATCTTTNCA-----------------TTGATGAAGCGATAGAATGGTTTAGTTTAGAAAATCTTTCCAGTTCTCCGGCTCATTTTA
TTGATGAAGCGTTAGAATGGTTTAGTTTAGAAAACCTTTCTAATTCCCCAGCTCATTTTA
****** ** ******** *** ********* **** *

NJ
S3 & S4
26695
TC

ANTTAAANNNTT--AAANNCTTNANCNNCGAGCATTTNANGCTTTTAGACNANGA---------------------------------------------------------------ATTTAAAATATTTAAAACACTTAAACCACGAGCATTTAAAGCTTTTAGACGATGACAAGT
ATTTAAAATATTTAAAACACTTAAACCACCAGCATTTAAAGCGTTTAGATGATGAAAAAT

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------TATTAGAACTCACTTCAATAAAAGATAAAAACCTCTTAGGGCTTTTAAGATTGTTTATAG
TATTAGAGCTTTCTCAAATAAAAGATAGGAATCTTTTAGGGCTTTTAAGATTATTCATAG

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------AAGAATGCGGCACGCTTTTAGAATTGAGGGAAAAAATTTCGTTGTTTTTAGAGCCAAAGG
AAGAATGCGATACGCTTTTAGAATTGAAAGAAAAAATTTCGTTGTTTTTAGAGCCAAAAG

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------ATATTGTTAAAACTTATGAAAATGAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACG
ATATTGTTAAAACTTATGAAAACGAAGATTTTAAAGAGCGCTGCTCAATACTTTTTAACG

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------CTCTAACAAGCATGGATTTTCAAGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCA
CCCTAAAAAGCATGGATTTTCAAGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCA

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------TGCGATTAAGCCAGCTTAAGGGTAAGGATTTTTTCAAACCTTTGCGCATCCTTTTAACCG
TGTGATTAAGCCAGCTTAAAGGTAAAGATTTTTTTAAACCTTTGCGCATTCTTTTAATTG

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------GGAACTCGCATGGCGTTGAATTGCCTTTGATTTTCCCCTATATCCAAAGCCATCATCAAG
GGGATTCGCATGGCGTTGAATTGCCTTTGATTTTCCCTTATATTCAAAGCCATTATCAAG

NJ
S3 & S4
26695
TC

--------------------------------------------AAGTTTTAAGGCTCAAAGCATGA
AAGTTTTAAGGCTCAAAGCATGA
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Figure 2.3: Alignment of sequencing data using reverse primers for the strain
Cheetah gltx2. NJ; S3 and S4 – data from different sequencing trials. TC – Data from Dr.
Terry Cathopulis. 26695 – Data from H pylori genome
NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------ATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCACATAGGGAATTTAAGGGCAGCC
ATGCTTCGTTTTGCGCCTTCGCCTACTGGGGATATGCACATAGGGAATTTAAGGGCAGCC

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------ATTTTCAACTACATTGTGGCTAAACAGCAATATAAACCCTTTCTCATTCGCATTGAAGAC
ATTTTTAACTATATTGTGGCTAAACAGCAACATAAACCCTTTCTCATTCGCATTGAAGAC

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------ACAGACAAAGAGCGCAACATTGAAGGCAAAGACCAAGAGATTTTAGAAATTTTAAAGCTT
ACAGATAAAGAGCGCAATATTGAAGGCAAAGATCAGGAGATTTTAGAGATTCTAAAGCTC

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------ATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCATAATATAGATTACCACAGAGAA
ATGGGAATGAACTGGGATAAACTCGTGTATCAAAGCCATAACATAGATTACCATAGGGAA

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------ATGGCAGAAAAATTACTGAAAGAAAATAAAGCGTTTTATTGTTATGCGAGTGCGGAGTTT
ATGGCAGAAAAATTGCTTAAAGAAAATAAGGCGTTTTATTGTTATGCGAGTGTGGGATTT

NJ
S3 & S4
26695
TC

----------------------------------------------------------------------------------------------------------------------TTAGAAAGAGAAAAAGAAAAAGCCAAAAATGAAAAACGCCCTTTCAGGTATTCAGACGAG
TTAGAACAAGAAAAAGAAAAAGCCAAAAACGAAAAACGCCCTTTCAGGTATTTAGATGAA

NJ
S3 & S4
26695
TC

------------------------------------GNGN-GNGNTNAAAAGCCCCAAAT
------------------------NNCCATGCCCCNGNGN-GCGTTNAAAAGCCCCAAAT
TGGGCCACTTTAGAAAAAGACAAGCACCATGCCCCTGTGGTGCGTTTAAAAGCCCCAAAT
TGGGCGGCTTTAGAGAAAAACCAGCACAATACCCCTGTGGTGCGTTTAAA-GCCCCAAAT
* * * * * *** *********

NJ
S3 & S4
26695
TC

CATGNNNNNTNTTT-NNNGATGCGATTAAAAAG-AAGTGAAATTTGAANCNGATGAATNG
CNTGCGNNGTCTTC-AACGATGCGATTAAAAANGAAGTGAAATTTGANNNG-ATGAATNG
CATGCGGTGTCTTTCAACGATGCGATTAAAAAAGAAGTGAAATTTGAACCTGATGAATTG
CATGCGGTGTCTTTTAACGATGCGATTAAAAAAGAAGTGAAATTTGAGCCTTATGAATTG
* **
* **
************** *************
****** *

NJ
S3 & S4
26695
TC

GATTCTTTTGNGCTTTTGAGACAGGATAAAAGCCCTACTTATAATTTCGCTTGCGCATGC
GATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCNNACTTATAATTTCGCTTGCGCATGC
GATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACTTATAATTTCGCTTGCGCATGC
GATTCTTTTGTGCTTTTAAGAAAGGATAAGAGCCCTACTTATAATTTCGCTTGTGCATGC
********** ****** *** ******* **** ***************** ******

NJ
S3 & S4
26695
TC

GATGATTTGCTTTATAAAATCAGTCTGATTATTTGCGGCGAAGATCATGTGAGTAACACC
GATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGCGAAGATCATGTGAGTAACACC
GATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGCGAAGATCATGTGAGTAACACC
GATGATTTGCTTTATGAAATCAGTCTTATTATTAGGGGCGAAGATCATGTGAGTAACACC
*************** ********** ****** * ************************

NJ
CCCCAAANCAANTCTTAATCCAGCAAGCTTTAGGCTCCAATGATCCGATTGTTTATGCGC
S3 & S4 CCCCAAAC-AANTCTTANTCCAGCAAGCTTTAGGCTCCAATGATCCGATTGTTTATGCGC
26695
CCC-AAAC-AAATCTTAATCCAGCAAGCTTTAGGCTCCAATGATCCGATTGTTTATGCGC

24
TC

CCT-AAAC-AAATCTTAATCCAACAAGCTTTAGGCTCCAACAACCCTATTATTTATGCAC
** *** ** ***** **** ***************** * ** *** ******* *

NJ
S3 & S4
26695
TC

ATTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATGAGTAAAAGAGATGAAGCCT
ATTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATGAGTAAAAGAGATGAAGCCT
ATTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATGAGTAAAAGAGATGAAGCCT
ATTTGCCCATTATCTTAGATGAAGCAAGCGGTAAAAAGATGAGCAAAAGGGATGAAGCCT
************* ********** ****************** ***** **********

NJ
S3 & S4
26695
TC

CCAGCGTGAAATGGCTTTTGAATCAAGGGTTTTTACCGGTTGCGATTGCGAATTACCTCA
CCAGCGTGAAATGGCTTTTGAATCAAGGGTTTTTACCGGTTGCGATTGCGAATTACCTCA
CCAGCGTGAAATGGCTTTTGAATCAAGGGTTTTTACCGGTTGCGATTGCGAATTACCTCA
CTAGCGTGAAATGGCTTTTAAATCAAGGGTTTTTGCCGGTTGCTATTGTGAATTACCTCA
* ***************** ************** ******** **** ***********

NJ
S3 & S4
26695
TC

TCACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGATGAAGCGATAGAATGGT
TCACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGATGAAGCGATAGAATGGT
TCACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGATGAAGCGATAGAATGGT
TCACTATTGGTAATAAAGTGCCTAAAGAAGTTTTTAGCCTTGATGAAGCGTTAGAATGGT
******* ***************** ************************ *********

NJ
S3 & S4
26695
TC

TTAGTTTAGAAAATCTTTCCAGTTCTCCGGCTCATTTTAATTTAAAATATTTAAAACACT
TTAGTTTAGAAAATCTTTCCAGTTCTCCGGCTCATTTTAATTTAAAATATTTAAAACACT
TTAGTTTAGAAAATCTTTCCAGTTCTCCGGCTCATTTTAATTTAAAATATTTAAAACACT
TTAGTTTAGAAAACCTTTCTAATTCCCCAGCTCATTTTAATTTAAAATATTTAAAACACT
************* ***** * *** ** *******************************

NJ
S3 & S4
26695
TC

TAAACCACGAGCATTTAAAGCTTTTAGACGATGACAAGTTATTAGAACTCACTTCAATAA
TAAACCACGAGCATTTAAAGCTTTTAGACGATGACAAGTTATTAGAACTCACTTCAATAA
TAAACCACGAGCATTTAAAGCTTTTAGACGATGACAAGTTATTAGAACTCACTTCAATAA
TAAACCACCAGCATTTAAAGCGTTTAGATGATGAAAAATTATTAGAGCTTTCTCAAATAA
******** ************ ****** ***** ** ******** ** ** *****

NJ
S3 & S4
26695
TC

AAGATAAAAACCTCTTAGGGCTTTTAAGATTGTTTATAGAAGAATGCGGCACGCTTTTAG
AAGATAAAAACCTCTTAGGGCTTTTAAGATTGTTTATAGAAGAATGCGGCACGCTTTTAG
AAGATAAAAACCTCTTAGGGCTTTTAAGATTGTTTATAGAAGAATGCGGCACGCTTTTAG
AAGATAGGAATCTTTTAGGGCTTTTAAGATTATTCATAGAAGAATGCGATACGCTTTTAG
****** ** ** ***************** ** ************* **********

NJ
S3 & S4
26695
TC

AATTGAGGGAAAAAATTTCGTTGTTTTTAGAGCCAAAGGATATTGTTAAAACTTATGAAA
AATTGAGGGAAAAAATTTCGTTGTTTTTAGAGCCAAAGGATATTGTTAAAACTTATGAAA
AATTGAGGGAAAAAATTTCGTTGTTTTTAGAGCCAAAGGATATTGTTAAAACTTATGAAA
AATTGAAAGAAAAAATTTCGTTGTTTTTAGAGCCAAAAGATATTGTTAAAACTTATGAAA
****** ***************************** **********************

NJ
S3 & S4
26695
TC

ATGAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACGCTCTAACAAGCATGGATTTTC
ATGAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACGCTCTAACAAGCATGGATTTTC
ATGAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACGCTCTAACAAGCATGGATTTTC
ACGAAGATTTTAAAGAGCGCTGCTCAATACTTTTTAACGCCCTAAAAAGCATGGATTTTC
* ***************** ** * *
*********** **** **************

NJ
S3 & S4
26695
TC

AAGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGCGATTAAGCCAGCTTAAGG
AAGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGCGATTAAGCCAGCTTAAGG
AAGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGCGATTAAGCCAGCTTAAGG
AAGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGTGATTAAGCCAGCTTAAAG
***************************************** **************** *

NJ
S3 & S4
26695
TC

GTAAGGATTTTTTCAAACCTTTGCGCATCCTTTTAACCGGGAACTCGCATGGCGTTGAAT
GTAAGGATTTTTTCAAACCTTTGCGCATCCTTTTAACCGGGAACTCGCATGGCGTTGAAT
GTAAGGATTTTTTCAAACCTTTGCGCATCCTTTTAACCGGGAACTCGCATGGCGTTGAAT
GTAAAGATTTTTTTAAACCTTTGCGCATTCTTTTAATTGGGGATTCGCATGGCGTTGAAT
**** ******** ************** ******* *** * ****************

NJ
S3 & S4
26695
TC

TGCCTTTGATTTTCCCCTATATCCAAAGCCATCATCAAGAAGTTTTTAAGGCTCAAAGCA
TGCCTTTGATTTTCCCCTATATCCAAAGCCATCATCAAGAAGTTTTTAAGGCTCAAAGCA
TGCCTTTGATTTTCCCCTATATCCAAAGCCATCATCAAGAAGTTTT-AAGGCTCAAAGCA
TGCCTTTGATTTTCCCTTATATTCAAAGCCATTATCAAGAAGTTTT-AAGGCTCAAAGCA
**************** ***** ********* ************* *************

NJ
TGACCCGGGGGAAAGGGCGAATTCCAGCACACTGGCGGCCGTTACTNNNNNTCCGAGS3 & S4 TGACCCGGGGGAAAGGGCGAATTCCAGCACACTGGCGGCCGTTACTNNNNNTCCGAGN
26695
TGA-------------------------------------------------------

25
TC

TGA------------------------------------------------------***
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One region of about 5 bp in the gltX2 gene in the Cheetah straingave ambiguous
signals in every sequencing attempt (Red box in Figure 2). As these ambiguous bases
are silent in the translated protein product, they do not impact conclusions about the
variability of gltX2.
The gltX2 gene from R7 was PCR amplified using primers NJ201 and NJ202. The
products were cloned into the TOPO pCR2.1 vector and sequenced. Similar to the
Cheetah strain, the sequences showed a number of mismatches compared to our
earlier results and the data aligned with very good agreement to the gltX2 gene from Hp
26695.These results are shown in Figures 4 and 5. Based on these data, we have
concluded that strain R7 gltX2 is not truncated as originally suspected.

Figure 2.4: Alignment of sequencing data using M13forward(M13f) primer for the
strain R7 gltx2. TC – Data from Dr. Terry Cathopoulis, 26695 – data from H. pylori genome
M13f
26695
TC

NGGCGANTGGGCCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGCAG 60
-----------------------------------------------------------------------------------------------------------------------

M13f
26695
TC

AATTCGCCCTTCGGGATCCATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCACAT 120
-------------------ATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCACAT 41
-------------------ATGCTTCNTTTTGCGCCTTCGCCTACAGGGGATATGCACAT 41
******* *********************************

M13f
26695
TC

AGGGAATTTAAGGGCAGCCATTTTCAACTACATTGTGGCTAAACAGCAATATAAACCCTT 180
AGGGAATTTAAGGGCAGCCATTTTCAACTACATTGTGGCTAAACAGCAATATAAACCCTT 101
AGGGAATTTAAGGGCAGCCATTTTTAACTACATTGTGGCCAAACAGCAACATAAACCCTT 101
************************ ************** ********* **********

M13f
26695
TC

TCTCATTCGCATTGAAGACACAGACAAAGAGCGCAACATTGAAGGCAAAGACCAAGAGAT 240
TCTCATTCGCATTGAAGACACAGACAAAGAGCGCAACATTGAAGGCAAAGACCAAGAGAT 161
TCTCATTCGCATTGAAGACACAGATAAAGAACGCAACATTGAAGGCAAAGATCAAGAGAT 161
************************ ***** ******************** ********

M13f
26695
TC

TTTAGAAATTTTAAAGCTTATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCATAA 300
TTTAGAAATTTTAAAGCTTATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCATAA 221
TTTAGAGATTTTAAAGCTTATGGGGATAAGTTGGGATAAACTCGTGTATCAAAGCCATAA 221
****** *********************** ***** ** ********************

M13f
26695
TC

TATAGATTACCACAGAGAAATGGCAGAAAAATTACTGAAAGAAAATAAAGCGTTTTATTG 360
TATAGATTACCACAGAGAAATGGCAGAAAAATTACTGAAAGAAAATAAAGCGTTTTATTG 281
CATAGATTACCACAGAGAAATGGCAGAAAAATTGCTTAAGGAAAATAAAGCGTTTTATTG 281
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******************************** ** ** ********************
M13f
26695
TC

TTATGCGAGTGCGGAGTTTTTAGAAAGAGAAAAAGAAAAAGCCAAAAATGAAAAACGCCC 420
TTATGCGAGTGCGGAGTTTTTAGAAAGAGAAAAAGAAAAAGCCAAAAATGAAAAACGCCC 341
CTATGCGAGCGCGGAATTTTTAGAACAAGAAAAAGAAAAAGCCAAAAACGAAAAACGCCC 341
******** ***** ********* ********************* ***********

M13f
26695
TC

TTTCAGGTATTCAGACGAGTGGGCCACTTTAGAAAAAGACAAGCACCATGCCCCTGTGGT 480
TTTCAGGTATTCAGACGAGTGGGCCACTTTAGAAAAAGACAAGCACCATGCCCCTGTGGT 401
TTTCAGGTATTTAGACGAATGGGCGACTTTAGAAAAAGACAAGCACCATGATCCTGTGGT 401
*********** ****** ***** ************************* ********

M13f
26695
TC

GCGTTTAAAAGCCCCAAATCATGCGGTGTCTTTCAACGATGCGATTAAAAAAGAAGTGAA 540
GCGTTTAAAAGCCCCAAATCATGCGGTGTCTTTCAACGATGCGATTAAAAAAGAAGTGAA 461
GCGTTTAAAAGCCCCAAATCATGCGGTTTCTTTTAATGATGCGATCAAAAAAGAAGTGAA 461
*************************** ***** ** ******** **************

M13f
26695
TC

ATTTGAACCTGATGAATTGGATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACTTA 600
ATTTGAACCTGATGAATTGGATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACTTA 521
ATTTGAACCTTATGAATTGGATTCTTTTGTGCTTTTAAGAAAGGATAAAAGCCCGACTTA 521
********** ************************* *** ************* *****

M13f
26695
TC

TAATTTCGCTTGCGCATGCGATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGCGA 660
TAATTTCGCTTGCGCATGCGATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGCGA 581
TAATTTCGCTTGCGCATGCGATGATTTGCTTTATGAAATCAGTCTGATTATTAGAGGCGA 581
********************************** *************************

M13f
26695
TC

AGATCATGTGAGTAACACCCCCAAACAAATCTTAATCCAGCAAGCTTTAGGCTCCAATGA 720
AGATCATGTGAGTAACACCCCCAAACAAATCTTAATCCAGCAAGCTTTAGGCTCCAATGA 641
AGATCACGTGAGTAACACCCCTAAACAGATTTTAATCCAACAAGCTTTAGGCTCAAATGA 641
****** ************** ***** ** ******** ************** *****

M13f
26695
TC

TCCGATTGTTTATGCGCATTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATGAG 780
TCCGATTGTTTATGCGCATTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATGAG 701
CCCTATTATTTATGCGCATTTACCCATTATCTTAGATGAAGCAAGCGGTAAAAAAATGAG 701
** *** ************* ******** ********** ************ *****

M13f
26695
TC

TAAAAGAGATGAAGCCTCCAGCGTGAAATGGCTTTTGAATCAAGGGTTTTTANCGGTTGC 840
TAAAAGAGATGAAGCCTCCAGCGTGAAATGGCTTTTGAATCAAGGGTTTTTACCGGTTGC 761
CAAAAGAGACGAAGCCTCTAGCGTGAAATGGCTTTTAAATCAAGGGTTTTTGCCGGTTGC 761
******** ******** ***************** ************** *******

M13f
26695
TC

GATTGCGAATTACCTCATCACTATCGGTAATAAAGTGCCTAANGAAGTTTTTAGCCTTGA 900
GATTGCGAATTACCTCATCACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGA 821
GATCGTGAATTACCTCATCACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGA 821
*** * ************************************ *****************

M13f
26695
TC

TGAAGCGATAGAATGGTTTAGTTTAGAAAATCTTTNCAGTNCTCNNNCTCNTTTTNATTT 960
TGAAGCGATAGAATGGTTTAGTTTAGAAAATCTTTCCAGTTCTCCGGCTCATTTTAATTT 881
TGAAGCGATAGAATGGTTCAGTTTGGAAAACCTTTCTAATTCCCCGGCTCATTTTAATTT 881
****************** ***** ***** **** * * * *
*** **** ****

M13f
26695
TC

AAAATATTTAAAN--NCNNANNNNCNAGCATTTAA-GCTTTTNGACGATGANN------- 1010
AAAATATTTAAAACACTTAAACCACGAGCATTTAAAGCTTTTAGACGATGACAAGTTATT 941
AAAATACTTAAAACACTTAAACCACCAACATTTAAAGCGTTTAGACGATGAAAAATTATT 941
****** *****
*
* * ******* ** *** ********

M13f
26695
TC

-----------------------------------------------------------AGAACTCACTTCAATAAAAGATAAAAACCTCTTAGGGCTTTTAAGATTGTTTATAGAAGA 1001
AGAACTCGCCCCAACAAAAGATAAAAATCTTTTAGGGCTTTTAAGGTTATTCATAGAAGA 1001

M13f

------------------------------------------------------------
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26695
TC

ATGCGGCACGCTTTTAGAATTGAGGGAAAAAATTTCGTTGTTTTTAGAGCCAAAGGATAT 1061
ATGCGGCACGCTTTTAGAATTGAAAGAAAAAATTTCGTTGTTTTTAGAGCCAAAAGATAT 1061

M13f
26695
TC

-----------------------------------------------------------TGTTAAAACTTATGAAAATGAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACGCTCT 1121
TGTTAAAACTTACGAAAACGAAGATTTTAAAGAGCGTTGCTCAATTCTTTTTAACGCCCT 1121

M13f
26695
TC

-----------------------------------------------------------AACAAGCATGGATTTTCAAGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGCG 1181
AAAAAGCATGGATTTTCAAGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGTG 1181

M13f
26695
TC

-----------------------------------------------------------ATTAAGCCAGCTTAAGGGTAAGGATTTTTTCAAACCTTTGCGCATCCTTTTAACCGGGAA 1241
ATTGAGCCAGCTTAAGGGTAAGGATTTTTTCAAACCCTTGCGCATTCTTTTAACCGGAAA 1241

M13f
26695
TC

-----------------------------------------------------------CTCGCATGGCGTTGAATTGCCTTTGATTTTCCCCTATATCCAAAGCCATCATCAAGAAGT 1301
CTCGCATGGCGTTGAATTGCCGTTGATTTTCCCTTATATTCAAAGCCATTATCAAGAAGT 1301

M13f
26695
TC

------------------TTTAAGGCTCAAAGCATGA 1320
TTTAAGGCTCAAAGCATGA 1320
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Figure 2.5: Alignment of sequencing data using M13reverse (M13r) primer for the
strain R7 gltx2. TC – Data from Dr. Terry Cathopoulis, 26695 – data from H. pylori genome
M13r
26695
TC

-----------------------------------------------------------ATGCTTCGTTTTGCGCCTTCGCCTACAGGGGATATGCACATAGGGAATTTAAGGGCAGCC 60
ATGCTTCNTTTTGCGCCTTCGCCTACAGGGGATATGCACATAGGGAATTTAAGGGCAGCC 60

M13r
26695
TC

-----------------------------------------------------------ATTTTCAACTACATTGTGGCTAAACAGCAATATAAACCCTTTCTCATTCGCATTGAAGAC 120
ATTTTTAACTACATTGTGGCCAAACAGCAACATAAACCCTTTCTCATTCGCATTGAAGAC 120

M13r
26695
TC

-----------------------------------------------------------ACAGACAAAGAGCGCAACATTGAAGGCAAAGACCAAGAGATTTTAGAAATTTTAAAGCTT 180
ACAGATAAAGAACGCAACATTGAAGGCAAAGATCAAGAGATTTTAGAGATTTTAAAGCTT 180

M13r
26695
TC

-----------------------------------------------------------ATGGGGATAAGCTGGGACAAGCTCGTGTATCAAAGCCATAATATAGATTACCACAGAGAA 240
ATGGGGATAAGTTGGGATAAACTCGTGTATCAAAGCCATAACATAGATTACCACAGAGAA 240

M13r
26695
TC

-----------------------------------------------------------ATGGCAGAAAAATTACTGAAAGAAAATAAAGCGTTTTATTGTTATGCGAGTGCGGAGTTT 300
ATGGCAGAAAAATTGCTTAAGGAAAATAAAGCGTTTTATTGCTATGCGAGCGCGGAATTT 300

M13r
26695
TC

-----------------------------------------------------------TTAGAAAGAGAAAAAGAAAAAGCCAAAAATGAAAAACGCCCTTTCAGGTATTCAGACGAG 360
TTAGAACAAGAAAAAGAAAAAGCCAAAAACGAAAAACGCCCTTTCAGGTATTTAGACGAA 360

M13r
26695
TC

-----------------------------------NNNNGNGCGTTTAAAAGCCCCAAAT 25
TGGGCCACTTTAGAAAAAGACAAGCACCATGCCCCTGTGGTGCGTTTAAAAGCCCCAAAT 420
TGGGCGACTTTAGAAAAAGACAAGCACCATGATCCTGTGGTGCGTTTAAAAGCCCCAAAT 420
* *******************

M13r
26695
TC

CNTGNGNNNTCTT-CAACGATGCGATTAAAAAAGAAGTGAAATT--GANNNGATGAATTG 82
CATGCGGTGTCTTTCAACGATGCGATTAAAAAAGAAGTGAAATTTGAACCTGATGAATTG 480
CATGCGGTTTCTTTTAATGATGCGATCAAAAAAGAAGTGAAATTTGAACCTTATGAATTG 480
* ** *
**** ** ******** *****************
*
********

M13r
26695
TC

GATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCNNACTTATAATTTCGCTTGCGCNTGC 142
GATTCTTTTGTGCTTTTGAGACAGGATAAAAGCCCTACTTATAATTTCGCTTGCGCATGC 540
GATTCTTTTGTGCTTTTAAGAAAGGATAAAAGCCCGACTTATAATTTCGCTTGCGCATGC 540
***************** *** ************ ******************** ***

M13r
26695
TC

GATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGCGAAGATCATGTGAGTAACACC 202
GATGATTTGCTTTATAAAATCAGTCTGATTATTAGAGGCGAAGATCATGTGAGTAACACC 600
GATGATTTGCTTTATGAAATCAGTCTGATTATTAGAGGCGAAGATCACGTGAGTAACACC 600
*************** ******************************* ************

M13r
26695
TC

CCCCAAACAANTCTTAATCCAGCAAGCTTTAGGCTCCAATGATCCGATTGTTTATGCGCA 262
CCC-AAACAAATCTTAATCCAGCAAGCTTTAGGCTCCAATGATCCGATTGTTTATGCGCA 659
CCT-AAACAGATTTTAATCCAACAAGCTTTAGGCTCAAATGACCCTATTATTTATGCGCA 659
** ***** * ******** ************** ***** ** *** **********

M13r
26695
TC

TTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATGAGTAAAAGAGATGAAGCCTC 322
TTTGCCCATTATTTTAGATGAAGTAAGCGGTAAAAAGATGAGTAAAAGAGATGAAGCCTC 719
TTTACCCATTATCTTAGATGAAGCAAGCGGTAAAAAAATGAGCAAAAGAGACGAAGCCTC 719
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*** ******** ********** ************ ***** ******** ********
M13r
26695
TC

CAGCGTGAAATGGCTTTTGAATCAAGGGTTTTTACCGGTTGCGATTGCGAATTACCTCAT 382
CAGCGTGAAATGGCTTTTGAATCAAGGGTTTTTACCGGTTGCGATTGCGAATTACCTCAT 779
TAGCGTGAAATGGCTTTTAAATCAAGGGTTTTTGCCGGTTGCGATCGTGAATTACCTCAT 779
***************** ************** *********** * ************

M13r
26695
TC

CACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGATGAAGCGATAGAATGGTT 442
CACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGATGAAGCGATAGAATGGTT 839
CACTATCGGTAATAAAGTGCCTAAGGAAGTTTTTAGCCTTGATGAAGCGATAGAATGGTT 839
************************************************************

M13r
26695
TC

TAGTTTAGAAAATCTTTCCAGTTCTCCGGCTCATTTTAATTTAAAATATTTAAAACACTT 502
TAGTTTAGAAAATCTTTCCAGTTCTCCGGCTCATTTTAATTTAAAATATTTAAAACACTT 899
CAGTTTGGAAAACCTTTCTAATTCCCCGGCTCATTTTAATTTAAAATACTTAAAACACTT 899
***** ***** ***** * *** *********************** ***********

M13r
26695
TC

AAACCACGAGCATTTAAAGCTTTTAGACGATGACAAGTTATTAGAACTCACTTCAATAAA 562
AAACCACGAGCATTTAAAGCTTTTAGACGATGACAAGTTATTAGAACTCACTTCAATAAA 959
AAACCACCAACATTTAAAGCGTTTAGACGATGAAAAATTATTAGAACTCGCCCCAACAAA 959
******* * ********** ************ ** ************ * *** ***

M13r
26695
TC

AGATAAAAACCTCTTAGGGCTTTTAAGATTGTTTATAGAAGAATGCGGCACGCTTTTAGA 622
AGATAAAAACCTCTTAGGGCTTTTAAGATTGTTTATAGAAGAATGCGGCACGCTTTTAGA 1019
AGATAAAAATCTTTTAGGGCTTTTAAGGTTATTCATAGAAGAATGCGGCACGCTTTTAGA 1019
********* ** ************** ** ** **************************

M13r
26695
TC

ATTGAGGGAAAAAATTTCGTTGTTTTTAGAGCCAAAGGATATTGTTAAAACTTATGAAAA 682
ATTGAGGGAAAAAATTTCGTTGTTTTTAGAGCCAAAGGATATTGTTAAAACTTATGAAAA 1079
ATTGAAAGAAAAAATTTCGTTGTTTTTAGAGCCAAAAGATATTGTTAAAACTTACGAAAA 1079
***** ***************************** ***************** *****

M13r
26695
TC

TGAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACGCTCTAACAAGCATGGATTTTCA 742
TGAAGATTTTAAAGAGCGTTGTTTAGCGCTTTTTAACGCTCTAACAAGCATGGATTTTCA 1139
CGAAGATTTTAAAGAGCGTTGCTCAATTCTTTTTAACGCCCTAAAAAGCATGGATTTTCA 1139
******************** * *
*********** **** ***************

M13r
26695
TC

AGCGTATAAGGATTTTGANAGTTTTAAAAAAGAAGCCATGCGATTAAGCCAGCTTAAGGG 802
AGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGCGATTAAGCCAGCTTAAGGG 1199
AGCGTATAAGGATTTTGAAAGTTTTAAAAAAGAAGCCATGTGATTGAGCCAGCTTAAGGG 1199
****************** ********************* **** **************

M13r
26695
TC

TAAGGATTTTTTCAAACCTTTGCGCATCCTTTTAACCGGGAACTCGCATGGCGTTGAATT 862
TAAGGATTTTTTCAAACCTTTGCGCATCCTTTTAACCGGGAACTCGCATGGCGTTGAATT 1259
TAAGGATTTTTTCAAACCCTTGCGCATTCTTTTAACCGGAAACTCGCATGGCGTTGAATT 1259
****************** ******** *********** ********************

M13r
26695
TC

GCCTTTGATTTTCCCCTATATCCAAAGCCATCATCAAGAAGTTTTTAAGGCTCAAAGCAT 922
GCCTTTGATTTTCCCCTATATCCAAAGCCATCATCAAGAAGTTTT-AAGGCTCAAAGCAT 1318
GCCGTTGATTTTCCCTTATATTCAAAGCCATTATCAAGAAGTTTT-AAGGCTCAAAGCAT 1318
*** *********** ***** ********* ************* **************

M13r
26695
TC

GACCCGGGGGAAAGGGCGAATTCCAGCACACNGGCGGCCGTTACTAGNGGNNCCGAGNNC 982
GA---------------------------------------------------------- 1320
GA---------------------------------------------------------- 1320

III. Conclusion
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While Dr.Cathopoulis’s original results were intriguing, upon further examination,
they are unfortunately most likely the result of PCR errors.
The gltX2 genes from strains B3, R7, and Cheetah were shown to be full-length
and highly homologous to gltX2 from Hp26695.
Thus, the 16 strains of Hp that we analyzed have highly homologous gltX2 genes.
Therefore, even though Hp has a high rate of evolution, gltX2 seems to be under robust
selection pressures to maintain its current primary sequence.
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IV. Materials and Methods
Genes were PCR amplified using primers listed in Table 2.1 and Pfu polymerase
according to the manufacturer’s instructions. Cloning into the TOPO pCR2.1 vector was
done according to the procedure in the TOPO manual (Invitrogen).14
Table 2.1: Primers used in this study.
Primer

Sequence

NJ201

GCTTGGCGTTAGCCAAGTGCTAATCTCTTAAATGATGCC

NJ202

CGTAATGAGCGAGCTTAAAATCACCGCTATCGC

S3

CGGGATCCATGCTTCGTTTTGCGCCTTCG

S4

TCCCCCGGGTCATGCTTTGAGCCTTAAAAACTTC

NJ205

GCGTTTTATTGTTATGCG

NJ206

GCCCCAAATCATGCGG

NJ207

GCCATTTCACGC

NJ208

CGCTTCATCAAGGC

All sequencing was done by the sequencing facility at Wayne State University,
Medical School using the M13forward and M13reverse primers.
All alignments were performed using ClustalW2.6
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Chapter III
Investigating the mechanism of ammonia transport in the tunnel of H. pylori
GatCAB
I. Introduction
The first crystal structure of GatCAB (from Staphylococcus aureus) was reported in
2006.10 Recently, a second structure was reported, using the enzyme from Aquifex
aeolicus.15 These structures show that the two distal active sites in GatA and GatB are
connected by a putative hydrophilic tunnel that is filled with several ordered water
molecules. While other enzymes with ammonia tunnels are known,

22

the GatCAB

enzyme is the first example of a highly hydrophilic tunnel.10 This observation makes
GatCAB an unusual enzyme with an apparently novel mechanism of ammonia delivery.
The ammonia molecule, generated by hydrolysis of glutamine in the active site of
GatA, is transported through a putative 37 Å tunnel, to the active site of GatB. The
presence of ordered waters, as well as conserved acidic and basic amino acids,
throughout this tunnel seem to suggest transport of ammonia by successive protonation
and deprotonation steps.10 Glu125 (in GatB) lies close to the interface of GatA and
GatB; this residue had been proposed to be a regulatory gate for the transport of
ammonia.10 The crystal structure of Aquifex aeolicus

15

however, suggests that the

channel connects the two active sites of GatA and GatB without the presence of a gate.
No consensus regarding the role of glutamate has emerged so far. Furthermore, the
presence of an active site base near GatB should be essential for the delivery of neutral
ammonia for its nucleophilic attack, however this putative base remains unknown.
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The goal of this project was to develop an understanding of the mechanism of
ammonia transport through the H. pylori GatCAB tunnel. An alignment reveals that all
the acidic and basic residues in the tunnel are conserved amongst all known bacterial
GatCAB orthologs.10 Kinetic analyses will be used to quantify the impact of conservative
and non-conservative mutations at these positions to gain insight into their roles in the
mechanism of ammonia transport. The above goal will be accomplished in three steps:
Step 1: Optimize an assay for H. pylori GatCAB-catalyzed transamidation of GlutRNAGln.
Step 2: Apply this assay to an analysis of point mutations throughout the GatCAB
ammonia tunnel.
Step 3: Combine kinetic results with molecular modeling to develop a mechanism for
GatCAB-catalyzed ammonia transport.

II. Results and Discussion
A. Preparation of materials

E. coli BL21 (DE3) competent cells carrying the plasmid pSS003 (GatB) were
transformed with pPTC032 (GatCA). (The plasmids introduce an N-terminal 6-His tag to
GatB and GatC, respectively). The resultant cells were used to overexpress GatCAB
and the enzyme was purified by Ni2+- affinity chromatography.. In order to isolate only
the complex from the eluates, size-exclusion chromatography (SEC) was used as a
second purification step (Figure 3.2). The concentration of GatCAB, as determined by
UV absorbance, was 93 µM.
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Figure

3.2:

Purification

of

HpGatCAB. A) SEC chromatogram
2+

of the eluate obtained from Ni
affinity

chromatography.

Five

fractions were collected. Based on
times of elution and molecular weight
the boxed region was identified as
GatCAB. B) SDS-PAGE of this region
confirmed the presence of GatCAB.
The impurity at 26 kD was attributed
to a degradation product of GatB.

The plasmid encoding a six-histidine tagged variant of the CCA-adding enzyme was
generously provided by Dr. Rebecca Alexander of Wake Forest University. The CCAadding enzyme, required for the first step of the [32P] tRNA/nuclease P1assay (Figure
3.5, also see the discussion below), was over expressed and purified by cobalt affinity
chromatography (Figure 3.3). The concentration was determined by UV absorbance to
be 55 µM.
Figure 3.3: Purification of CCA-adding enzyme.
The CCA-adding enzyme was overexpressed and
purified by cobalt affinity chromatography. Analysis
by SDS-PAGE gel shows that the enzyme is pure.
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B. Optimization of an assay for H. pylori GatCAB-catalyzed transamidation of GlutRNAGln.
The net reaction catalyzed by GatCAB is the transamidation of Glu-tRNAGln to
produce Gln-tRNAGln. This activity can be monitored by thin-layer electrophoresis (TLE)
or two different thin-layer chromatographic (TLC) methods.16 We initially sought to
optimize our TLE assay in order to use it as a quantitative measure of GatCAB kinetics.
This technique separates

14

C-labeled glutamate from glutamine (following hydrolysis

from the tRNA) via electrophoresis on a TLC plate. However, several attempts (using a
GatCAB concentration of 310 nM) failed to give clear resolution of time points over a
reaction time course. A final assay, with 10 µM enzyme, was carried out over 120 min.
In this case, only 12 – 25% conversion was observed and quantification by
phosphorimager was inaccurate. These results led us to conclude that GatCAB was
active, but that TLE/14C-phosphorimaging was not sensitive enough for kinetic
resolution.
Figure 3.4: TLE assay of transamidation
catalyzed by 10 µM HpGatCAB. Time
points of 30, 60, 90 and 120 min are shown.
Control spots of

14

C-labeled Glu and Gln are

on the left and right, respectively. A no
enzyme control (-ve) is also included.
Conversion of Glu to Gln is observed but is
non-linear.

Next, we decided to use the [32P] tRNA/nuclease P1 assay for our system. This
assay is based on the incorporation of

32

P-ATP into the 3’-end of the tRNA, using the
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CCA-adding enzyme, and subsequent treatment of the reaction with P1 nuclease.17
Figure 3.5 shows a summary of this assay: the 3’ AMP of tRNA is exchanged with
ATP by the CCA adding enzyme, incorporating a

32

P-

32

P label between the last two

nucleotides of the tRNA (Figure 3.5A). Aminoacylation and transamidation reactions
take place on the radioactive terminal nucleotide of tRNAGln (Figures 3.5B and 3.5C).
Digestion of tRNAGln with P1 nuclease cleaves the terminal nucleotide with the attached
amino acids (Figure 3.5D). TLC and phosphorimaging are used to resolve, visualize,
and quantify the starting material (Glu-AMP) and products (Gln-AMP) (Figure 3.5E).

Figure 3.5:

17

32

[ P] tRNA/nuclease P1 assay for transamidation catalyzed by H. pylori
Gln

GatCAB. A) Transfer RNA
32

is labeled with
Gln

and α− P-ATP. B) The labeled tRNA
Gln

is converted to Gln-tRNA

32

P by treatment with the CCA adding enzyme
Gln

is aminoacylated with Glu by GluRS2. C) Glu-tRNA

by GatCAB. D) Digestion of by nuclease P1 gives three possible

products in the form of labeled AMPs. E) These products are separated and visualized by
TLC and phosphorimaging, respectively.
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This assay required optimization before kinetic analyses were possible. The result of
an initial attempt is shown in Figure 3.6. A spot above Glu-AMP did appear over time,
suggesting that it is Gln-AMP. However, the two spots were not well resolved.
Figure 3.6: Initial attempt at a

32

P-based

transamidation assay. Time points (5 µL) were
quenched in a P1 nuclease mix and spotted 1 cm
from the base of a PEI – cellulose plate. A no
enzyme control was also conducted. The plate was
run in 100 mM ammonium acetate in 5% acetic acid.
Gln-AMP grows in over time, but with poor resolution

Based on a report on the detection of nucleotides by mass spectrometry,

20

pre-

treatment of the TLC plates with ammonium hydroxide was tested to improve resolution.
While this method afforded good resolution, ammonium hydroxide corroded the plates,
causing the PEI-Cellulose matrix to disintegrate. Another report suggested pretreatment with water.21 This procedure yielded good resolution while maintaining plate
integrity (Figure 3.7).
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Figure 3.7: Improved resolution. Pre-treatment
of the TLC plate with water improves resolution.
The assay was performed with 200 nM of AdT.
Time points were taken at one minute intervals.

Next, we set out to identify conditions for measuring initial rates (Figure 3.8).
Enzyme concentration and time points were varied. GatCAB concentrations below 10
nM gave less than 10% conversion of Glu to Gln (ideal for measuring initial rate
kinetics). The last optimization of the assay was focused on the observation of an extra
spot in the no enzyme control lanes (Figure 3.9). This spot has the same Rf value as
Gln-AMP and its intensity varied from 30% to 60% (normalized with respect to Glu-AMP
and Gln-AMP). Such a high percentage was not desirable for kinetic analyses and
efforts were sought to resolve this impurity. A number of steps summarized in Section III
brought the intensity down to 3%.
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Figure 3.8: Conditions for measuring initial rates. High concentrations of AdT (200 nM and 50 nM)
show greater than 10% conversion of the substrate to the product in less than 1 min. Lowering the
enzyme concentration to 20 nM or 10 nM leads to a slower increase (bottom left graph). The best
results were observed with less than 10 nM GatCAB (1 nM GatCAB shown here).
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Figure 3.9: High intensity of the negative control
spot. A spot of comparable intensity (red box) with
the time-points was observed for the no AdT control.
The exact origin of this spot is unclear. A no P1
nuclease treatment shows an absence of the spot
indicating

that

this

is

not

a

small

molecule

contamination from the preparation of the GluGln

tRNA

.

A final assay with 5 nM GatCAB and all the conditions described above is shown in
Figure 3.10.
Figure 3.10: Final conditions for the
assay. The extra spot in the negative
control lane is now reduced to 3%. Also, a
positive control (prepared by using 400 nM
GatCAB over 1 hr) confirms the identity of
Gln-AMP. The increase is linear over the
time range tested.

The conditions shown in Figure 3.10 were repeated in triplicate, however, large
variations were observed from trial to trial. A representative triplicate assay is shown in
Figure 3.11.
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Figure 3.11: Representative triplicate
assay. Each line represents one trial.
Large deviations are seen from trial to trial.

We attributed these deviations in slope (two-fold in Figure 3.11) to errors in pipetting
small volumes (1 µL) of enzyme stored in 50% glycerol. Enzyme dilution led to higher
reproducibility but much higher levels of conversion (Figure 3.12). Lowering the enzyme
concentration to 1 nM resolved this issue (Figure 3.13).
Figure 3.12:

Eliminating effects of

glycerol. Dilution of the enzyme in water
leads

to

better

various trials.

agreement

between
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Figure 3.13: A representative image of a
transamidation assay: A phosphorimage of
transamidation with 1 nM AdT is shown. The
Gln

negative control is of Glu-tRNA

treated with P1

nuclease (no AdT). The positive control is GlnGln

tRNA

Gln

formed by aminoacylation of Hp tRNA

by E. coli GlnRS.

C. Hp GatCAB shows a biphasic response
Figure 3.14: Biphasic response of
GatCAB:

An

transamidation
Transamidation
response,

initial
by

rate
1

shows

probably

profile

of

nM

GatCAB.

a

biphasic

due

to

the

accumulation of the misacylated product.
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An initial rate profile of transamidation by GatCAB shows a biphasic response
towards transamidation. This is most likely due to accumulation of the correctly acylated
product. As Gln-tRNAGln accumulates over time, it is possible that it becomes a
competing substrate to Glu-tRNAGln leading to a reduced rate of transamidation.

D. An analysis of point mutations throughout the GatCAB ammonia tunnel.
QuikChange site-directed mutagenesis was used to construct two mutations in GatA
(D185A and D185N) and four mutations in GatB (K89A, K89R, Y91A, and Y91F); the
entire open reading frame of each clone was sequenced in its entirety. The remaining
mutations in Table 3.1 were constructed by other members of the lab.
GatA

GatB

T149A,T149S,T149V

R79A,R79K

R174A,R174K

K80A,K80R

S182A,S182T

Y82A,Y82S

D185A,D185N

K89A,K89R

R323A,R323K

Y91A,Y91F

Table 3.1: Proposed
mutations in GatCAB.

Q92A,Q92E
E125A,E125Q,E125D
D278A,D278N

The four mutants in the GatB subunit, K89A, K89R, Y91A and Y91F, were coexpressed with wild-type GatCA and purified as a complex by cobalt affinity
chromatography. We found that using cobalt resin instead of Nickel resin gave higher
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purity and SEC was not required to further purify these mutants (Figure 3.15). The
remaining mutants in Table 3.1 were purified by other members of the lab.
Figure 3.15: Purification of GatB mutants. Each
of the GatB mutants was co-expressed with wildtype GatCA. They were purified as a complex by
cobalt affinity chromatography. SDS-PAGE of the
purified fractions is shown here.

The impact of some of these mutants on initial rates of transamidation is shown in
Figure 3.16. A general conclusion that can be drawn is that the ammonia tunnel is
sensitive to mutagenesis.
Figure 3.16 Effect
of

mutants

GatCAB’s

on
initial

rate

of

transamidation:
Most mutations are
deleterious

to

enzyme activity. For
a detailed discussion
on each mutant, see
text.
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Residues in GatA: Conservative mutations in GatA (T149V, S182T and D185N)
completely abolish transamidation activity. Alanine mutations, however, tend to have
~40% activity. It remains to be seen if this is a general feature of the residues in GatA
that line the tunnel.
Residues in GatB: Out of all the mutants screened so far, K80R is the only mutant that
shows wild-type activity. This result implies that a positive charge near the GatB active
site is important for efficient transamidation. For the remaining residues, alanine
mutations completely abolished transamidation activity implying an important role for
these residues. Glu125, a residue at the interface of GatA and GatB, shows 50%
activity when it is mutated to E125Q and E125D, implying that the charged side chain
as well as its size play important roles. Tyr82, a potential base near the GatB active site
that could deprotonate ammonium to the nucleophilic ammonia necessary for
transamidation, shows 50% activity when mutated to phenylalanine. This result
suggests that Tyr82 is not serving as a base, however, the role of its aromatic side
chain seems important. Tyr91, another residue near the interface of GatA and GatB,
has no transamidation activity upon alanine mutation. This residue has been implicated
in domain-domain communication.13
III. Conclusions
Two mutations in GatA (D185A and D185N) and four mutations in GatB (K89A,
K89R, Y91A, and Y91F) have been constructed. The GatB mutants were co-expressed
with wild-type GatCA and purified by cobalt affinity chromatography.
The [32P] tRNA/nuclease P1 assay was optimized for our system by making a
number of changes:
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•

Dilution (10X) after synthesis of labeled tRNAGln and labeled Glu-tRNAGln followed
by concentration by passing the mixture through a 3k spin column. This removes
small molecule impurities as well as unreacted radioactive ATP.

•

Addition of 18 µM unlabeled Glu-tRNAGln to the GatCAB reaction mixture.

•

Pre-treatment of the TLC plate with water

•

Solvent system – Water:1M NH4Cl:Acetic acid (85:10:5)

•

Initiation of the reaction by adding Gln and ATP

•

Diluting AdT from a 50% glycerol stock to water and using a higher volume (5 µL) to
avoid errors in pipeting solution containing glycerol

Preliminary results suggest that T149, S182 and D185 in GatA while K80, Y82, Y91
and E125 in GatB are important for transamidation.

IV. Materials and Methods
Unless otherwise stated, all materials were purchased from Sigma-Aldrich or
Fisher Scientific.
Site-directed mutagenesis
QuikChange site-directed mutagenesis was performed on the plasmids pPTC032
(containing N-terminally tagged gatCA genes in an operon)11 and pSS003 (N-terminally
tagged gatB gene).12 The primers used for each mutation are listed in Table 2.
Typically, a polymerase chain reaction (50 µL) was conducted under the following
conditions: 95 °C10.00; [95 °C1.30;65 °C1.00;72 °C3.00]30; 72 °C10.00 . DNA (1 µL, OD=0.5), 4
mM dNTPs, 1 mM primers and 1 µM Pfu polymerase(New England Biolabs) were used.
The products were loaded on an agarose gel (treated with ethidium bromide). Agarose
gel chromatography was used to confirm the expected products. The open reading
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frames of each plasmid were confirmed by DNA sequencing at the sequencing facility at
Wayne State University Medical School.
Table 3.2: Primers used for GatA and GatB mutagenesis. The capital letters in the primer
sequence indicate the positions of the nucleotides that were mutated.

Primer Mutation
NJ07

K89A

NJ08
NJ26

K89R

Y91A

Y91F

NJ35

gatttgcctaaggcttTtcaaatttcgcagtttgaag
cttcaaactgcgaaatttgaAaagccttaggcaaatc

D185A

NJ33
NJ34

gatttgcctaaggctGCtcaaatttcgcagtttgaag
cttcaaactgcgaaatttgaGCagccttaggcaaatc

NJ31
NJ32

ggaaaaattatttttaccctgatttgcctCGggcttatcaaatttcgc
gcgaaatttgataagccCGaggcaaatcagggtaaaaataatttttcc

NJ29
NJ30

ggaaaaattatttttaccctgatttgcctGCggcttatcaaatttcgc
gcgaaatttgataagccGCaggcaaatcagggtaaaaataatttttcc

NJ27
NJ28

Sequence

cgcgtattgctctagttttgCtcaaatcgggcc
ggcccgatttgaGcaaaactagagcaatacgcg

D185N

cgcgtattgctctagttttAatcaaatcgggcc
ggcccgatttgatTaaaactagagcaatacgcg

Purification of wild-type and mutant GatCAB variants
E. coli BL21 (DE3) competent cells carrying the plasmid pSS003 encoding GatB12
were transformed with pPTC032 encoding GatCA.11 (These plasmids introduce Nterminal 6-His tags onto GatB and GatC, respectively). These two plasmids contain two
different antibiotic genes and two different origins of replication. Due to this, it is
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possible to introduce two plasmids in one cell. The resultant cells were used to
overexpress GatCAB and the enzyme complex was purified by Ni2+-affinity
chromatography. Eluted fractions were diluted to 1 mL in SEC buffer (50 mM Hepes, pH
7.2, 30 mM KCl, 6 mM MgCl2, 0.1 mM EDTA, 5 mM β-mercaptoethanol). The sample
was injected onto a Superdex 200 gel filtration column (Amersham). The fractions were
analyzed by SDS-PAGE. The fractions containing pure GatCAB were concentrated
using a YM-10 filter and stored in 50% glycerol.
The GatCAB mutants were transformed similar to wild-type above. The resultant
cells were used to overexpress the GatCAB mutants. The resulting complexes were
purified using cobalt affinity chromatography, since concentration of the purified
complex was found to be higher compared to nickel affinity chromatography. Also the
complex thus obtained did not contain significant impurities, thus avoiding size
exclusion chromatography. The purified fractions were stored in 50% glycerol.

Thin layer electrophoresis (TLE) assay
The TLE assay was performed as described previously.16

[32P]-tRNA/nuclease P1 assay
Polyethyleneimine-cellulose plates were purchased from EMD chemicals and P1
nuclease was purchased from Sigma-Aldrich. [α-32P] ATP was purchased from
American Radiolabeled Chemicals.
Transfer RNAGln was labeled with

32

P as previously reported with the following

changes;17 after phenol/chloroform extraction, the aqueous layer was diluted 10-fold and
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passed through a 3k spin column until the volume was reduced to 100 µL. Transfer
RNAGln was precipitated by isopropanol.
Glu-tRNAGln was prepared by mixing the

32

P-labeled tRNAGln with 37 µM unlabelled

tRNAGln. This mixture was incubated with 2 µM GluRS2, as described previously.9 The
resulting Glu-tRNAGln was purified and precipitated similar to tRNAGln above.
The efficiency of both tRNA labeling and Glu-tRNAGln synthesis was monitored by
liquid scintillation counting.
The assay was performed with the key steps listed in section III.Briefly, the
procedure was as follows. 18 µM unlabeled Glu-tRNAGln was added to the GatCAB
reaction mixture. The reaction mixture also contained 1nM of GatCAB, this was
prepared by diluting from a 50% glycerol stock to water and using a higher volume (5
µL) to avoid errors in pipeting solution containing glycerol.. Other components of the
reaction were as previously described.17 The reaction was initiated by adding glutamine
and ATP. The reaction was quenched as described.17 The TLC plate was pretreated
with water and dried. A solvent system of Water:1M NH4Cl:Acetic acid (85:10:5) was
used to develop the plates.
TLC plates were dried and exposed to a Kodak imaging screen for 16 hours. The
screens were imaged using a Typhoon phosphoimager. ImageQuant software was used
for analysis of the data. Kaleidagraph was used to plot and analyze the graphs shown in
the above figures.
V. References
1. Ibba, M., and Söll D. (2000) Aminoacyl-tRNA synthesis. Annu. Rev. Biochem.69,
617-650.
2. Arnez, J.G., Moras, D. (1997) Structural and functional consideration of the

52
aminoacylation reaction. Trends. Biochem. Sci.22, 211-216.

3. Cusack, S. (1997) Aminoacyl-tRNA synthetases. Curr. Opin. Struct. Biol.7, 881889.
4. Woese, C. R., Olsen, G. J., Ibba, M., and Söll, D. (2000) Aminoacyl-tRNA
synthetases, the genetic code, and the evolutionary process. Mol. Biol. Rev.64,
202-236.
5. Bult C.J., et al. (1996) The complete genome sequence of the methanogenic
archaeon, Methanococcusjannaschii.Science. 273, 1058-1073.
6. Cathopoulis, T., Chuawong, P., and Hendrickson, T. L. (2007) Novel tRNA
aminoacylation mechanisms. Mol. Biosyst.3 (6):408-18.
7. Tomb, J.F., et al. (1997) The complete genome sequence of the gastric pathogen
Helicobacter Pylori. Nature 388(6642):539-47.
8. Tumbula, D. L., Becker, H. D., Chang, W., Söll, D. (2000) Domain-specific
recruitment of amide amino acids for protein synthesis Nature.407, 106.
9. Skouloubris, S., Ribas de Pouplana, L., De Reuse, H., Hendrickson, T.L. (2003)
A noncognate aminoacyl-tRNA synthetase that may resolve a missing link in
protein evolution. Proc. Natl. Acad. Sci. U S A.100 (20):11297-302.
10. Nakamura, A., Yao, M., Chimnaronk, S., Sakai, N., Tanaka, I. (2006) Ammonia
channel

couples

glutaminase

with

transamidase

reactions

in

GatCAB.

Science.312 (5782):1954-1958.
11. Courtesy, Dr. Pitak Chuawong.
12. Courtesy, Dr. Stephane Skouloubris.
13. Zhao, L., et al. (2012) The kinase activity of H. Pylori Asp-tRNA(Asn)/GlutRNA(Gln) amidotransferase is sensitive to distal mutations in its putative

53
ammonia tunnel Bichemistry.51 (1):273-285.
14. Invitrogen (2006) TOPO TA Cloning: User Manual.
15. Wu, J., Bu, W., Sheppard, K., Kitabatake, M., Kwon, S. T., Soll, D., Smith, J.
L.(2009) Insights into tRNA-dependent amidotransferase evolution and catalysis
from the structure of the Aquifex aeolicus enzyme. J. Mol. Biol.391, 703-716.
16. Cathopoulis, T., Chuawong, P., and Hendrickson, T. L. (2007) A Thin-Layer
Electrophoresis Assay for Asp-tRNAAsn/Glu-tRNAGln Amidotransferase, Anal.
Biochem.360, 151-153.
17. Sheppard, K., Akochy, P.M., Soll, D. (2008) Assays for transfer-RNA dependent
amino acid biosynthesis. Methods.44, 139-145.
18. Curnow, et al. (1997) Glu-tRNAGln amidotransferase: A novel heterotrimeric
enzyme required for correct decoding of glutamine codons during translation
Proc. Natl.Acad.Sci.USA 94, 11819-11826.
19. Stratagene. QuikChange site-directed mutagenesis kit instruction manual.
20. Isbell, D.T., et al. (1999) Analysis of nucleotides directly from TLC plates using
MALDI-MS detection J. Anal. Chem.365: 625–630.
21. Wolfson, A. D, et al. (2002) Modulation of tRNAAla identity by inorganic
pyrophosphatase Proc. Natl. Acad. Sci. USA99, 5965-5970.
22. Raushel FM, Thoden JB, Holden HM. Enzymes with molecular tunnels.(2003)
Acc ChemRes.36(7):539-4.

54

ABSTRACT
INVESTIGATING THE GLUTAMINE-TRNA (GLUTAMINE) SYNTHESIS APPARTUS
OF THE HUMAN PATHOGEN HELICOBACTER PYLORI
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Accurate protein biosynthesis is a vital process to all cellular life. AminoacyltRNAs are at the heart of this process: A correctly formed aminoacyl-tRNA is critical for
protein biosynthesis. Organisms have evolved many mechanisms to repair misacylated
tRNAs before they cause errors in protein biosynthesis, thus maintaining the integrity of
the genetic code. The human pathogen Helicobacter pylori (H. pylori) synthesizes GlutRNAGln as an intermediate to producing Gln-tRNAGln. This misacylated intermediate
could cause lethal errors if used by the ribosome for protein synthesis. H. pylori repairs
this intermediate by the amidotransferase GatCAB.
This dissertation focuses on indirect aminoacylation and transamidation to
produce Gln-tRNAGln in H. pylori.

A combination of phylogenetic analyses and

enzymatic assays were used that contribute to a picture of this process.
Chapter 2 discusses our examination of sequence conservation of gltX2 (the gene
that encodes GluRS2) across different H. pylori strains. The conclusions of this
sequencing effort are compared with trends in sequences of genes important in the
aminoacylation step of protein synthesis.
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Chapter 3 discusses one aspect of Gln-tRNAGln production – the mechanism of
transport of ammonia from the active site of one subunit (GatA) to the active site of
another (GatB) through an intramolecular hydrophilic tunnel. Site-directed mutagenesis
of key residues lining this tunnel and their transamidation assays were performed. With
these studies, a preliminary picture of ammonia transport through the tunnel can be
constructed.

56

AUTOBIOGRAPHICAL STATEMENT
Nilesh Vasudeo Joshi
EDUCATION
MS, Chemistry, Wayne State University Detroit, MI – 2012
MSc, Chemistry, Indian Institute of Technology, Delhi, India – 2007
BSc, Chemistry, University of Mumbai, India – 2005
Relevant courses: Molecular Biology, Molecular Biophysics, Metabolism, Biochemistry, Quantum
Chemistry, Organic synthesis, Chemistry of natural products, Co-ordination chemistry

RESEARCH
Publication, accepted in Biochemistry, 2012: Zhao, L, et al. “The kinase activity of the Helicobacter pylori
Asn
Gln
Asp-tRNA /Glu-tRNA amidotransferase is sensitive to distal mutations in its putative ammonia tunnel”
Poster, 2011: “The mechanism of ammonia transport in GatCAB" at the 2011 International Symposium
on Aminoacyl-tRNA Synthetases in Salt Lake City, Utah.

WORK EXPERIENCE
National Chemical Laboratory, Pune, India (2005 and 2006) Summer KVPY fellow
Performed computational studies (Hartree-Fock calculations) on the ethane molecule, Researched
analyzed and prepared a report on the use of programming techniques in computational chemistry.
Indian Institute of Science, Bangalore, India (2004) Summer KVPY fellow
Synthesized a conjugated polymer poly-(dimethoxy p-phenylene xylylene) using the halo precursor route
Wayne State University, Detroit, USA (2008 – 2011) Graduate Teaching Assistant
• Responsibilities included conducting lectures; performing laboratory demonstrations of key
experimental procedures; grading exams, lab reports, assignments, homework of undergraduates at
above institutions
• Courses taught: General Organic Chemistry, Survey of Organic chemistry and Biochemistry,
Experimental techniques in Physical Chemistry, Laboratory techniques in Organic chemistry,
General and Inorganic Chemistry

SCHOLARSHIPS AND AWARDS
•
•
•
•

Recipient of KVPY fellowship funded by Dept. of Science and Technology, Government of India.
2003-2007
Recipient of ‘Special Appreciation Award (Academics)’ from Vice Chancellor, University of
Mumbai. 2005
Selected to attend the “Nurture Camp” under the National Initiative for Undergraduate Science.
2004-2005
National Top 1 %( out of 3000 candidates) in the National Graduate Examination in Physics.
2004

